Skip to main content

Quadrant Biosciences Recognized as New York Technology Business of the Year

We’re excited to share that our company, Quadrant Biosciences, has been recognized as the New York Technology Business of the Year for our breakthrough epigenetic research!

The award, presented by the New York State Small Business Development Center (SBDC),  recognizes the boldest, brightest, and best small companies in New York State.

Although Quadrant is a relatively young company, we’ve been able to make significant discoveries in the world of epigenetics. This is due, in large part, to our relationships with highly regarded epigenetic researchers at SUNY Upstate Medical University and Penn State College of Medicine, as well as financial support for the research from the American Academy of Pediatrics, the National Institutes of Health, and the Kirson-Kolodner-Fedder Charitable Fund.  But what really drives our work, as our Founder and CEO Rich Uhlig points out, is the desire to help others.

“We’re a different kind of company at our core,” explains Uhlig.  “We’re fundamentally in the service of others. That philosophy is shared by everyone at Quadrant and positively impacts everything we do.”

Quadrant’s business advisor at the Binghamton University SBDC, Chuck Schwerin, explained why he nominated the company for this award.  “Their epigenetic breakthrough may change the lives of countless individuals with neurological challenges whose conditions may now be detected far earlier than was thought possible. Rich [Uhlig] was a deserving winner of this year’s award, and I look forward to observing the impact the company will make in the coming years.”

We hope to continue to positively impact the lives of others as we further our epigenetic research around autism, Parkinson’s Disease, concussion and other public health challenges.

For more about the award, read the press release here.